CoChat

Analysis of Candida auris fungemia at a single facility in Kenya

Open access
Adam, Rodney D., Revathi, Gunturu, Okinda, Nancy, Fontaine, Melanie, Shah, Jasmit, Kagotho, Elizabeth, Castanheira, Mariana, Pfaller, Michael A., Maina, Daniel · 2019 · International Journal of Infectious Diseases
Cited by 72

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Background: Candida auris emerged as a human pathogen in 2009 and has subsequently been identified around the world as a cause of invasive candidiasis. Published clinical information on this organism consists primarily of case reports or case series of patients from multiple sources. Data from a single institution will allow us to examine risk factors for C. auris candidemia by comparison with other Candida species. Methods: Patients with candidemia were identified by the electronic medical record and reviewed for risk factors and outcome. Candida isolates were identified by Vitek2 Compact (bioMerieux, Marcy-l'Etoile, France) as Candida haemulonii, but species determinations for 21 of the isolates using published molecular and proteomic methods identified all as C. auris using published methods. Findings: From September 2010 to December 2016, C. auris accounted for 38% of 201 patients with candidemia, while C. albicans contributed 25%. C. auris patients had been hospitalized longer (mean 31 days vs. 13 days; p <0.001), were more likely to have central lines preceding candidemia than C. albicans patients (84% vs. 54%; p=<0.001) and had more commonly been treated with carbapenems (75% vs 54% for C. albicans [p=0.009]). Prolonged candidemia (=> 14 days) was documented in 18% but was not associated with development of in vitro resistance. The crude mortality was 29%, compared to 36% for C. albicans and 39% for other Candida spp. Interpretation: These findings suggest an opportunistic pathogen that may be less virulent, but difficult to eradicate and that control efforts should focus on antimicrobial usage. Funding: None Declaration of Interest: None of the authors has a conflict of interest to report. Ethical Approval: The study protocol was approved by the Ethics Committee of AKUHN with a waiver of individual consent.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2019.06.001

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 72

Metadata

Authors
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2019-08
Volume
85
Pages
182-187
ISSN
1201-9712 (ISSN-L)
OpenAlex
W2951239929
Cited by
72
References
14
FWCI
5.66
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Analysis of Candida auris fungemia at a single facility in Kenya. https://app.cochat.ai/papers/10.1016/j.ijid.2019.06.001
The paper
Adam, R. D., Revathi, G., Okinda, N., Fontaine, M., Shah, J., Kagotho, E., Castanheira, M., Pfaller, M. A., & Maina, D. (2019). Analysis of Candida auris fungemia at a single facility in Kenya. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2019.06.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.